49 related articles for article (PubMed ID: 19738029)
1. BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38- cells, through activation of protein kinase Cbeta.
Pellicano F; Copland M; Jorgensen HG; Mountford J; Leber B; Holyoake TL
Blood; 2009 Nov; 114(19):4186-96. PubMed ID: 19738029
[TBL] [Abstract][Full Text] [Related]
2. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
Järås M; Johnels P; Hansen N; Agerstam H; Tsapogas P; Rissler M; Lassen C; Olofsson T; Bjerrum OW; Richter J; Fioretos T
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16280-5. PubMed ID: 20805474
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitochondria induces apoptosis and reduces telomere length and activity in acute myeloid leukemia stem cells.
Valipour B; Davari S; Farahzadi R; Pourrasol S; Mehran N; Dizaji Asl K; Altaha SM; Hojjati Z; Nozad Charoudeh H
Cell Biochem Funct; 2023 Dec; 41(8):1477-1487. PubMed ID: 38014526
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) exert their anti-proliferative activity by interfering with Akt-mTOR signaling and bax:bcl-2 ratio modulation in cells from chronic myeloid leukemic patients.
Di Stefano C; Marfe G; Trawinska MM; Sinibaldi-Salimei P; Silvestri R; Amadori S; Abruzzese E
Cancer Sci; 2010 Apr; 101(4):991-1000. PubMed ID: 20704577
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of Hispidin-Fungal and Plant Polyketide.
Palkina KA; Ipatova DA; Shakhova ES; Balakireva AV; Markina NM
J Fungi (Basel); 2021 Apr; 7(5):. PubMed ID: 33922000
[TBL] [Abstract][Full Text] [Related]
6. Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date.
Fletcher L; Joshi SK; Traer E
Cancer Manag Res; 2020; 12():151-163. PubMed ID: 32021432
[TBL] [Abstract][Full Text] [Related]
7.
Pellicano F; Park L; Hopcroft LEM; Shah MM; Jackson L; Scott MT; Clarke CJ; Sinclair A; Abraham SA; Hair A; Helgason GV; Aspinall-O'Dea M; Bhatia R; Leone G; Kranc KR; Whetton AD; Holyoake TL
Blood; 2018 Apr; 131(14):1532-1544. PubMed ID: 29437554
[TBL] [Abstract][Full Text] [Related]
8.
Giudice V; Ricci P; Marino L; Rocco M; Villani G; Langella M; Manente L; Seneca E; Ferrara I; Pezzullo L; Serio B; Selleri C
Transl Med UniSa; 2016 Nov; 15():22-33. PubMed ID: 27896224
[TBL] [Abstract][Full Text] [Related]
9. Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.
Perrotti D; Silvestri G; Stramucci L; Yu J; Trotta R
Curr Drug Targets; 2017; 18(4):377-388. PubMed ID: 27307150
[TBL] [Abstract][Full Text] [Related]
10. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells.
Sinclair A; Park L; Shah M; Drotar M; Calaminus S; Hopcroft LE; Kinstrie R; Guitart AV; Dunn K; Abraham SA; Sansom O; Michie AM; Machesky L; Kranc KR; Graham GJ; Pellicano F; Holyoake TL
Blood; 2016 Jul; 128(3):371-83. PubMed ID: 27222476
[TBL] [Abstract][Full Text] [Related]
11. Where are we going with CML research?
Perrotti D
Leuk Suppl; 2012 Aug; 1(Suppl 2):S51-3. PubMed ID: 27175251
[TBL] [Abstract][Full Text] [Related]
12. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
Aljedai A; Buckle AM; Hiwarkar P; Syed F
PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
[TBL] [Abstract][Full Text] [Related]
13. Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.
Chen Y; Peng C; Abraham SA; Shan Y; Guo Z; Desouza N; Cheloni G; Li D; Holyoake TL; Li S
J Clin Invest; 2014 Sep; 124(9):3847-62. PubMed ID: 25105362
[TBL] [Abstract][Full Text] [Related]
14. Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development.
Mencalha AL; Corrêa S; Abdelhay E
Onco Targets Ther; 2014; 7():1247-54. PubMed ID: 25045273
[TBL] [Abstract][Full Text] [Related]
15. Manumycin induces apoptosis in prostate cancer cells.
Li JG; She MR; Lu CY; Wei SS; Xia PF; Lu ZS; Peng Q
Onco Targets Ther; 2014; 7():771-7. PubMed ID: 24899815
[TBL] [Abstract][Full Text] [Related]
16. The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.
Pellicano F; Scott MT; Helgason GV; Hopcroft LE; Allan EK; Aspinall-O'Dea M; Copland M; Pierce A; Huntly BJ; Whetton AD; Holyoake TL
Stem Cells; 2014 Sep; 32(9):2324-37. PubMed ID: 24806995
[TBL] [Abstract][Full Text] [Related]
17. The role of mitochondrial DNA damage and repair in the resistance of BCR/ABL-expressing cells to tyrosine kinase inhibitors.
Glowacki S; Synowiec E; Blasiak J
Int J Mol Sci; 2013 Aug; 14(8):16348-64. PubMed ID: 23965958
[TBL] [Abstract][Full Text] [Related]
18. p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice.
Velasco-Hernández T; Vicente-Dueñas C; Sánchez-García I; Martin-Zanca D
Cell Cycle; 2013 Jan; 12(1):122-32. PubMed ID: 23255106
[TBL] [Abstract][Full Text] [Related]
19. Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib.
Constance JE; Woessner DW; Matissek KJ; Mossalam M; Lim CS
Mol Pharm; 2012 Nov; 9(11):3318-29. PubMed ID: 22957899
[TBL] [Abstract][Full Text] [Related]
20. Pushing the limits of targeted therapy in chronic myeloid leukaemia.
O'Hare T; Zabriskie MS; Eiring AM; Deininger MW
Nat Rev Cancer; 2012 Jul; 12(8):513-26. PubMed ID: 22825216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
